United States - English - NLM (National Library of Medicine)

golden state medical supply, inc. - capecitabine (unii: 6804dj8z9u) (capecitabine - unii:6804dj8z9u) - - capecitabine is indicated for the: - adjuvant treatment of patients with stage iii colon cancer as a single agent or as a component of a combination chemotherapy regimen. - perioperative treatment of adults with locally advanced rectal cancer as a component of chemoradiotherapy. - treatment of patients with unresectable or metastatic colorectal cancer as a single agent or as a component of a combination chemotherapy regimen. - capecitabine is indicated for the: - treatment of patients with advanced or metastatic breast cancer as a single agent if an anthracycline- or taxane-containing chemotherapy is not indicated. - treatment of patients with advanced or metastatic breast cancer in combination with docetaxel after disease progression on prior anthracycline-containing chemotherapy. capecitabine is indicated for the: - treatment of adults with unresectable or metastatic gastric, esophageal, or gastroesophageal junction cancer as a component of a combination chemotherapy regimen. - treatment of adult

United States - English - NLM (National Library of Medicine)

aurobindo pharma limited - capecitabine (unii: 6804dj8z9u) (capecitabine - unii:6804dj8z9u) - capecitabine tablets are indicated for the: - adjuvant treatment o f patients with stage iii colon cancer as a single agent or as a component of a combination chemotherapy regimen. - perioperative treatment of adults with locally advanced rectal cancer as a component of chemoradiotherapy. - treatment of patients with unresectable or metastatic colorectal cancer as a single agent or as a component of a combination chemotherapy regimen. capecitabine tablets are indicated for the: - treatment of patients with advanced or metastatic breast cancer as a single agent if an anthracycline- or taxane-containing chemotherapy is not indicated. - treatment of patients with advanced or metastatic breast cancer in combination with docetaxel after disease progression on prior anthracycline-containing chemotherapy. capecitabine tablets are indicated for the: - treatment of adults with unresectable or metastatic gastric, esophageal, or gastroesophageal junction cancer as a component of a combination chemotherapy regime

United States - English - NLM (National Library of Medicine)

sun pharmaceutical industries, inc. - capecitabine (unii: 6804dj8z9u) (capecitabine - unii:6804dj8z9u) - capecitabine tablets are indicated for the: - adjuvant treatment of patients with stage iii colon cancer as a single agent or as a component of a combination chemotherapy regimen. - perioperative treatment of adults with locally advanced rectal cancer as a component of chemoradiotherapy. - treatment of patients with unresectable or metastatic colorectal cancer as a single agent or as a component of a combination chemotherapy regimen. capecitabine tablets are indicated for the: - treatment of patients with advanced or metastatic breast cancer as a single agent if an anthracycline- or taxane-containing chemotherapy is not indicated. - treatment of patients with advanced or metastatic breast cancer in combination with docetaxel after disease progression on prior anthracycline-containing chemotherapy. capecitabine tablets are indicated for the: - treatment of adults with unresectable or metastatic gastric, esophageal, or gastroesophageal junction cancer as a component of a combination chemotherapy regimen.

United States - English - NLM (National Library of Medicine)

lifestar pharma llc - capecitabine (unii: 6804dj8z9u) (capecitabine - unii:6804dj8z9u) - capecitabine is indicated for the: • adjuvant treatment of patients with stage iii colon cancer as a single agent or as a component of a combination chemotherapy regimen. • perioperative treatment of adults with locally advanced rectal cancer as a component of chemoradiotherapy. • treatment of patients with unresectable or metastatic colorectal cancer as a single agent or as a component of a combination chemotherapy regimen.   capecitabine is indicated for the: • treatment of patients with advanced or metastatic breast cancer as a single agent if an anthracycline- or taxane-containing chemotherapy is not indicated. • treatment of patients with advanced or metastatic breast cancer in combination with docetaxel after disease progression on prior anthracycline-containing chemotherapy. capecitabine is indicated for the: • treatment of adults with unresectable or metastatic gastric, esophageal, or gastroesophageal junction cancer as a component of a combination chemotherapy regimen. • treatment of adults with

United States - English - NLM (National Library of Medicine)

bluepoint laboratories - capecitabine (unii: 6804dj8z9u) (capecitabine - unii:6804dj8z9u) - - capecitabine tablets, usp are indicated for the: ● adjuvant treatment of patients with stage iii colon cancer as a single agent or as a component of a combination chemotherapy regimen. ● perioperative treatment of adults with locally advanced rectal cancer as a component of chemoradiotherapy. ● treatment of patients with unresectable or metastatic colorectal cancer as a single agent or as a component of a combination chemotherapy regimen. - capecitabine tablets usp are indicated for the: ● treatment of patients with advanced or metastatic breast cancer as a single agent if an anthracycline- or taxane-containing chemotherapy is not indicated. ● treatment of patients with advanced or metastatic breast cancer in combination with docetaxel after disease progression on prior anthracycline-containing chemotherapy. - capecitabine tablets usp are indicated for the: ● treatment of adults with unresectable or metastatic gastric, esophageal, or gastroesophageal junction cancer as a component of a combination chemother

United States - English - NLM (National Library of Medicine)

prodigy innovation, llc. - capecitabine (unii: 6804dj8z9u) (capecitabine - unii:6804dj8z9u) -

Malta - English - Medicines Authority

cipla europe n.v. uitbreidingstraat 80, 2600 antwerp, belgium - capecitabine - film-coated tablet - capecitabine 150 mg - antineoplastic agents

Malta - English - Medicines Authority

cipla europe n.v. uitbreidingstraat 80, 2600 antwerp, belgium - capecitabine - film-coated tablet - capecitabine 500 mg - antineoplastic agents

Ireland - English - HPRA (Health Products Regulatory Authority)

fresenius kabi oncology plc - capecitabine - film-coated tablet - 150 milligram(s) - pyrimidine analogues; capecitabine

Malta - English - Medicines Authority

arrow generics limited whiddon valley barnstaple, north devon, ex32 8ns, united kingdom - capecitabine - film-coated tablet - capecitabine 150 mg - antineoplastic agents